Skip to main content

Clarus Group, Inc.

SEC CIK
0001844568
Latest filing
Jul 24, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Clarus Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,057
Value
$517.5K
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Clarus Group, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,057$517.5K0.2%+6+0.3%AddedHolders
Q1 20262,051$446.0K0.2%−181−8.1%ReducedHolders
Q4 20252,232$509.9K0.2%+5+0.2%AddedHolders
Q3 20252,227$515.6K0.2%+5+0.2%AddedHolders
Q2 20252,222$412.4K0.2%+6+0.3%AddedHolders
Q1 20252,216$464.4K0.2%+44+2.0%AddedHolders
Q4 20242,172$386.0K0.1%−447−17.1%ReducedHolders
Q3 20242,619$517.1K0.2%−133−4.8%ReducedHolders
Q2 20242,752$472.0K0.2%−742−21.2%ReducedHolders
Q1 20243,494$636.3K0.4%+7+0.2%AddedHolders
Q4 20233,487$540.3K0.4%−490−12.3%ReducedHolders
Q3 20233,977$592.8K0.4%−269−6.3%ReducedHolders
Q2 20234,246$572.1K0.4%+491+13.1%AddedHolders
Q1 20233,755$598.4K0.6%+106+2.9%AddedHolders
Q4 20223,649$589.6K0.5%−554−13.2%ReducedHolders
Q3 20224,203$564.0K0.5%+6+0.1%AddedHolders
Q2 20224,197$643.0K0.5%+6+0.1%AddedHolders
Q1 20224,191$679.0K0.5%−92−2.1%ReducedHolders
Q4 20214,283$494.0K0.3%+8+0.2%AddedHolders
Q3 20214,275$461.0K0.3%−40−0.9%ReducedHolders
Q2 20214,315$503.0K0.4%−100−2.3%ReducedHolders
Q1 20214,415$465.0K0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.